v3.26.3
Balance Sheet Details - Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2026
Jun. 30, 2025
Balance Sheet Related Disclosures [Abstract]    
Accrued compensation and benefits [1] $ 656 $ 873
Accrued legal and professional services 75 144
Accrued pre-clinical and clinical trial expenses 11 134
Derivative liabilities - Covered Call Options 40 0
Other 26 27
Total accrued liabilities $ 808 $ 1,178
[1] Includes employee termination benefits of approximately $0.7 million for the fiscal year ended June 30, 2025, as more fully described in Note 6. Employee Termination Benefits.